Alcon Inc. (ALC)

USD 84.74

(-0.94%)

Revenue Summary of Alcon Inc.

  • Alcon Inc.'s latest annual revenue in 2023 was 10.09 Billion USD , up 15.77% from previous year.
  • Alcon Inc.'s latest quarterly revenue in 2024 Q2 was 2.51 Billion USD , up 2.12% from previous quarter.
  • Alcon Inc. reported a annual revenue of 8.71 Billion USD in annual revenue 2022, up 5.14% from previous year.
  • Alcon Inc. reported a annual revenue of 8.29 Billion USD in annual revenue 2021, up 21.34% from previous year.
  • Alcon Inc. reported a quarterly revenue of 2.45 Billion USD for 2024 Q1, down -0.79% from previous quarter.
  • Alcon Inc. reported a quarterly revenue of 2.42 Billion USD for 2023 Q2, up 2.98% from previous quarter.

Annual Revenue Chart of Alcon Inc. (2023 - 2015)

Historical Annual Revenue of Alcon Inc. (2023 - 2015)

Year Revenue Revenue Growth
2023 10.09 Billion USD 15.77%
2022 8.71 Billion USD 5.14%
2021 8.29 Billion USD 21.34%
2020 6.83 Billion USD -8.99%
2019 7.5 Billion USD 4.96%
2018 7.15 Billion USD 5.32%
2017 6.79 Billion USD 2.97%
2016 6.59 Billion USD 1.2%
2015 6.51 Billion USD 0.0%

Peer Revenue Comparison of Alcon Inc.

Name Revenue Revenue Difference
AptarGroup, Inc. 3.48 Billion USD -189.379%
Baxter International Inc. 14.81 Billion USD 31.871%
Becton, Dickinson and Company 20.17 Billion USD 49.985%
Bausch + Lomb Corporation 4.14 Billion USD -143.414%
Haemonetics Corporation 1.3 Billion USD -670.933%
Envista Holdings Corp 2.56 Billion USD -293.218%
ResMed Inc. 4.68 Billion USD -115.396%
Teleflex Incorporated 2.97 Billion USD -239.283%
Warby Parker Inc. 669.76 Million USD -1406.787%
West Pharmaceutical Services, Inc. 2.94 Billion USD -242.123%